Post-approval studies (Phase 4)Study completedNCT01733199
What this trial is testing
Behavioural Addictions Occurring During a Dopaminergic Treatment Prescribe Under Parkinson's Disease: Study of the Psychopathological, Neurological, Pharmacokinetic and Genetic Profiles
Who this might be right for
Parkinson's DiseaseSecondary Behavioural Addiction
Nantes University Hospital 225